Gary L Goldberg - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gary L Goldberg

Showing results (71-80 of 126) with videos related to

Pageof 13

Sort By:

Cancer Biology & Therapy|September 24, 2010

Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6Rébécca Phaeton, Matthew Harris, Zewei Jiang, et al.

Gynecologic Oncology|March 27, 2016

Germline mutations of the DNA repair pathways in uterine serous carcinomaMarina Frimer, Kelly S Levano, Alicia Rodriguez-Gabin, et al.

Gynecologic Oncology|October 16, 2007

Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcomaGloria S Huang, Lydia G Chiu, Juliana S Gebb, et al.

Biochemistry|November 30, 2005

Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomicsPascal Verdier-Pinard, Shohreh Shahabi, Fang Wang, et al.

Gynecologic Oncology Reports|August 14, 2023

Stress, anxiety, and illness perception in patients experiencing delay in operative care due to the COVID-19 pandemicMichelle A Soloff, Trey Keel, Aaron Nizam, et al.

Cancer Biology & Therapy|March 28, 2007

Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapyDineo Khabele, Deok-Soo Son, Angelika K Parl, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009

Genetic variants in TAP are associated with high-grade cervical neoplasiaMark H Einstein, Suzanne Leanza, Lydia G Chiu, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011

Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinomaDivya Gupta, Marc J Gunter, Kathleen Yang, et al.

American Journal of Obstetrics and Gynecology|February 10, 2009

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcomaGloria S Huang, Rebecca C Arend, Maomi Li, et al.

Cancer Research|October 26, 2021

BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell CarcinomasMatthew L Fisher, Seamus Balinth, Yon Hwangbo, et al.

Pageof 13

Search research articles

Showing results (71-80 of 126) with videos related to

Sort By:

Pageof 13

Cancer Biology & Therapy|September 24, 2010

Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6Rébécca Phaeton, Matthew Harris, Zewei Jiang, et al.

Gynecologic Oncology|March 27, 2016

Germline mutations of the DNA repair pathways in uterine serous carcinomaMarina Frimer, Kelly S Levano, Alicia Rodriguez-Gabin, et al.

Gynecologic Oncology|October 16, 2007

Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcomaGloria S Huang, Lydia G Chiu, Juliana S Gebb, et al.

Biochemistry|November 30, 2005

Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomicsPascal Verdier-Pinard, Shohreh Shahabi, Fang Wang, et al.

Gynecologic Oncology Reports|August 14, 2023

Stress, anxiety, and illness perception in patients experiencing delay in operative care due to the COVID-19 pandemicMichelle A Soloff, Trey Keel, Aaron Nizam, et al.

Cancer Biology & Therapy|March 28, 2007

Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapyDineo Khabele, Deok-Soo Son, Angelika K Parl, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009

Genetic variants in TAP are associated with high-grade cervical neoplasiaMark H Einstein, Suzanne Leanza, Lydia G Chiu, et al.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011

Performance of serum CA125 as a prognostic biomarker in patients with uterine papillary serous carcinomaDivya Gupta, Marc J Gunter, Kathleen Yang, et al.

American Journal of Obstetrics and Gynecology|February 10, 2009

Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcomaGloria S Huang, Rebecca C Arend, Maomi Li, et al.

Cancer Research|October 26, 2021

BRD4 Regulates Transcription Factor ΔNp63α to Drive a Cancer Stem Cell Phenotype in Squamous Cell CarcinomasMatthew L Fisher, Seamus Balinth, Yon Hwangbo, et al.

Pageof 13